Bausch Health Cos Operating Expenses 2010-2024 | BHC
Bausch Health Cos operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Bausch Health Cos Annual Operating Expenses (Millions of US $) |
2023 |
$7,794 |
2022 |
$7,670 |
2021 |
$7,984 |
2020 |
$7,351 |
2019 |
$8,804 |
2018 |
$10,764 |
2017 |
$8,622 |
2016 |
$10,240 |
2015 |
$8,920 |
2014 |
$6,205 |
2013 |
$6,179 |
2012 |
$3,401 |
2011 |
$2,127 |
2010 |
$1,291 |
2009 |
$639 |
Bausch Health Cos Quarterly Operating Expenses (Millions of US $) |
2024-09-30 |
$2,192 |
2024-06-30 |
$2,014 |
2024-03-31 |
$1,872 |
2023-12-31 |
$2,046 |
2023-09-30 |
$2,224 |
2023-06-30 |
$1,755 |
2023-03-31 |
$1,769 |
2022-12-31 |
$2,437 |
2022-09-30 |
$1,802 |
2022-06-30 |
$1,806 |
2022-03-31 |
$1,625 |
2021-12-31 |
$1,829 |
2021-09-30 |
$1,537 |
2021-06-30 |
$2,370 |
2021-03-31 |
$2,248 |
2020-12-31 |
$2,218 |
2020-09-30 |
$1,678 |
2020-06-30 |
$1,691 |
2020-03-31 |
$1,764 |
2019-12-31 |
$3,300 |
2019-09-30 |
$1,880 |
2019-06-30 |
$1,895 |
2019-03-31 |
$1,729 |
2018-12-31 |
$2,096 |
2018-09-30 |
$2,019 |
2018-06-30 |
$2,373 |
2018-03-31 |
$4,276 |
2017-12-31 |
$2,485 |
2017-09-30 |
$2,181 |
2017-06-30 |
$2,058 |
2017-03-31 |
$1,898 |
2016-12-31 |
$2,253 |
2016-09-30 |
$3,342 |
2016-06-30 |
$2,339 |
2016-03-31 |
$2,306 |
2015-12-31 |
$2,591 |
2015-09-30 |
$2,339 |
2015-06-30 |
$2,391 |
2015-03-31 |
$1,599 |
2014-12-31 |
$1,617 |
2014-09-30 |
$1,372 |
2014-06-30 |
$1,686 |
2014-03-31 |
$1,530 |
2013-12-31 |
$1,840 |
2013-09-30 |
$2,433 |
2013-06-30 |
$954 |
2013-03-31 |
$951 |
2012-12-31 |
$1,018 |
2012-09-30 |
$855 |
2012-06-30 |
$733 |
2012-03-31 |
$795 |
2011-12-31 |
$658 |
2011-09-30 |
$488 |
2011-06-30 |
$491 |
2011-03-31 |
$490 |
2010-12-31 |
$564 |
2010-09-30 |
$335 |
2010-06-30 |
$190 |
2010-03-31 |
$203 |
2009-12-31 |
$182 |
2009-09-30 |
$154 |
2009-06-30 |
$183 |
2009-03-31 |
$120 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$3.439B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|